Source: Annual Congress 2011 - Imaging in COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. B. Shaker, A. Dirksen, P. Lo, L. T. Skovgaard, M. de Bruijne, J. H. Pedersen (Copenhagen, Denmark). Decline in lung density is accelerated in active smokers. Eur Respir J 2011; 38: Suppl. 55, 1883

Member's Comments

No comment yet.

Related content which might interest you: Smoking induced lung disease Source: Annual Congress 2010 - PG4 Core Curriculum Postgraduate Course: Pathology for the clinician Year: 2010 Predicting an accelerated lung function decline in smokers: is there a proper threshold? Source: Eur Respir J 2014; 43: 307-308 Year: 2004 Predicting an accelerated lung function decline in smokers: is there a proper threshold? Source: Eur Respir J 2014; 43: 308-309 Year: 2004 Estimating lung function decline and the effect of smoking in COPD patients Source: Eur Respir J 2002; 20: Suppl. 38, 578s Year: 2002 Regional lung function in nonsmokers and asymptomatic current and former smokers Source: ERJ Open Res, 5 (3) 00240-2018; 10.1183/23120541.00240-2018 Year: 2019 Decreased pulmonary mature dendritic cells in healthy smokers and smoking COPD patients Source: Eur Respir J 2007; 30: Suppl. 51, 212s Year: 2007 Frequent exacerbations in ex smokers with COPD are associated with accelerated rate of FEV1 decline Source: Eur Respir J 2005; 26: Suppl. 49, 510s Year: 2005 The variable relationship between changes in lung density and FEV1 in smokers Source: International Congress 2017 – Imaging markers for COPD and asthma Year: 2017 Budesonide/formoterol significantly improves lung function and reduces exacerbations in both smokers and ex-smokers with COPD Source: Eur Respir J 2006; 28: Suppl. 50, 430s Year: 2006 Impairment of lung function in asymptomatic smokers Source: Eur Respir J 2005; 26: Suppl. 49, 152s Year: 2005 Yearly progression of low lung attenuation area in low dose CT scan for aymptomatic current smokers with normal lung function or GOLD stage I COPD Source: Annual Congress 2013 –Lung function tests to monitor airway diseases Year: 2013 Lung function impairment in young AAT-deficient smokers Source: Annual Congress 2007 - Environmental and clinical aspects of COPD Year: 2007 Correlations between lung function, exhaled carbon monoxide and „lung age” in smokers versus former smokers with COPD Source: International Congress 2017 – Smoking and health hazards Year: 2017 Helium-hyperoxia accelerates O2 uptake kinetics compared to hyperoxia at the onset of high intensity exercise in hypoxaemic patients with COPD Source: Annual Congress 2010 - Peripheral and respiratory muscles oxygen transport during exercise Year: 2010 Effect of smoking cessation on lung function in a cohort of heavy smokers Source: Annual Congress 2010 - Therapy and health economics of asthma and COPD Year: 2010 Electronic nose distinguishes lung cancer from smoking and nonsmoking controls Source: Annual Congress 2010 - The role of biomarkers in lung cancer Year: 2010 Late Breaking Abstract: FAM13A gene confers reduced risk of COPD and lung cancer in current and former smokers Source: Annual Congress 2010 - Lung cancer, idiopathic pulmonary fibrosis and sarcoidosis: the genetic approach Year: 2010 Effects of cigarette smoking intensity on functional capacity of active smokers Source: Annual Congress 2013 –Exercise and physiotherapy in non-COPD conditions and in the assessment of healthy subjects Year: 2013 Influence of the association of smoking, COPD and rpulmonary tuberculosis on diffusion lung capacity Source: International Congress 2015 – Biomarkers in TB: immunology and physiology Year: 2015 Does the infection influence on induced sputum cell count at smokers and nonsmokers with COPD exacerbation? Source: Annual Congress 2009 - Exacerbations of COPD and bronchiectasis: aetiology and treatment Year: 2009